BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23731606)

  • 1. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.
    Atluri P; Goldstone AB; Kobrin DM; Cohen JE; MacArthur JW; Howard JL; Jessup ML; Rame JE; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Jul; 96(1):141-7. PubMed ID: 23731606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
    Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
    BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis.
    Cowger JA; Shah P; Pagani FD; Grafton G; Stulak J; Chamogeorgakis T; Lanfear D; Nemeh H; Pinney S
    J Heart Lung Transplant; 2020 May; 39(5):441-453. PubMed ID: 31831209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation.
    Kanwar MK; Lohmueller LC; Kormos RL; Teuteberg JJ; Rogers JG; Lindenfeld J; Bailey SH; McIlvennan CK; Benza R; Murali S; Antaki J
    JACC Heart Fail; 2018 Sep; 6(9):771-779. PubMed ID: 30098967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty and outcomes after implantation of left ventricular assist device as destination therapy.
    Dunlay SM; Park SJ; Joyce LD; Daly RC; Stulak JM; McNallan SM; Roger VL; Kushwaha SS
    J Heart Lung Transplant; 2014 Apr; 33(4):359-65. PubMed ID: 24486165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Tie H; Li Z; Welp H; Guha A; Caraballo C; Deschka H; Shi R; Zheng X; Martens S; Sindermann J; Chen D; Wu Q; Martens S
    ESC Heart Fail; 2024 Feb; 11(1):271-281. PubMed ID: 37967837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Determinants of Health and Outcomes After Pediatric Ventricular Assist Device Implantation.
    West CL; Zhao H; Cantor R; Sood V; Lal AK; Beaty C; Kirklin JK; Peng DM
    Pediatr Transplant; 2024 Aug; 28(5):e14802. PubMed ID: 38853134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracorporeal LVAD implantation in pediatric patients: A single-center 10 years' experience.
    Cao I; Italiano EG; Bertelli F; Motta R; Castaldi B; Pergola V; Guariento A; Scattolin F; Di Salvo G; Vida V; Padalino MA
    Artif Organs; 2024 Apr; 48(4):408-417. PubMed ID: 38380771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome.
    Cowger J; Shah P; Stulak J; Maltais S; Aaronson KD; Kirklin JK; Pagani FD; Salerno C
    J Heart Lung Transplant; 2016 Apr; 35(4):440-8. PubMed ID: 26683809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Intracorporeal Continuous and Paracorporeal Pulsatile Ventricular Assist Devices in Pediatric Patients 10-30 kg.
    Lee J; Shezad MF; Zafar F; Niebler RA
    ASAIO J; 2024 Jul; 70(7):616-620. PubMed ID: 38393712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet count in heart failure patients undergoing left ventricular assist device.
    Luo J; Li Z; Luo Y; Li T; Shi R; Chen D; Wu Q; Luo S; Huang B; Tie H
    ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38831637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices.
    Kyriakopoulos CP; Selzman CH; Giannouchos TV; Mylavarapu R; Sideris K; Elmer A; Vance N; Hanff TC; Kagawa H; Stehlik J; Drakos SG; Goodwin ML
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792411
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of center volume on outcomes after ventricular assist device implantation in pediatric patients: An analysis of the STS-Pedimacs database.
    Amdani S; Marino BS; Boyle G; Cassedy A; Lorts A; Morales D; Joong A; Burstein D; Bansal N; Sutcliffe DL
    J Heart Lung Transplant; 2024 May; 43(5):787-796. PubMed ID: 38199514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial Closure With Expanded Polytetrafluoroethylene Patch in Left Ventricular Assist Device Surgery.
    Meinert ÉFRC; Kremer J; Tochtermann U; Sommer W; Warnecke G; Karck M; Meyer AL
    ASAIO J; 2024 May; 70(5):371-376. PubMed ID: 38153977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In search of similarity in adverse events journeys of patients with left ventricular assist devices.
    Movahedi F; Pagani FD; Antaki JF
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):2147-2156.e3. PubMed ID: 37268103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter evaluation of the HeartMate 3 risk score.
    Grewal J; Tripathi N; Bortner B; Gregoski MJ; Cook D; Britt A; Hajj J; Rofael M; Sheidu M; Montovano MJ; Mehta M; Hajduczok AG; Rajapreyar IN; Brailovsky Y; Genuardi MV; Kanwar MK; Atluri P; Lander M; Shah P; Hsu S; Kilic A; Houston BA; Mehra MR; Sheikh FH; Tedford RJ
    J Heart Lung Transplant; 2024 Apr; 43(4):626-632. PubMed ID: 38061468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Assist Devices in Patients With Active Malignancies.
    Schlam I; Lee AY; Li S; Sheikh FH; Zaghlol R; Basyal B; Gallagher C; Molina E; Mahr C; Cheng RK; Barac A
    JACC CardioOncol; 2021 Jun; 3(2):305-315. PubMed ID: 34396339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care fragmentation predicts 90-day durable ventricular assist device outcomes.
    Funk RJ; Pagani FD; Hou H; Zhang M; Yang G; Malani PN; Chandanabhumma PP; Cabrera L; Kim KD; Likosky DS;
    Am J Manag Care; 2022 Dec; 28(12):e444-e451. PubMed ID: 36525664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.
    Bashir J; Legare JF; Freed DH; Cheung A; Rao V; Toma M
    Can J Cardiol; 2014 Dec; 30(12):1662-7. PubMed ID: 25475468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.